May 23 (Reuters) - German packaging and medical

equipment maker Gerresheimer said on Thursday it

signed a purchase agreement for acquiring Blitz LuxCo Sarl, the

holding company of the Bormioli Pharma Group, for an enterprise

value of 800 million euros ($866.32 million).

The medical equipment maker said the transaction will be

financed by a consortium of banks consisting of UniCredit,

Commerzbank and LBBW and is expected to close in

fourth quarter of 2024.

It will create a new 'moulded glass' business unit after the

integration, it said statement.

Injectors of the kind made by Gerresheimer are used to

administer Novo Nordisk's Wegovy and Eli Lilly's ( LLY )

Zepbound.

First-quarter earnings at Gerresheimer's primary packaging

glass division, which makes vials, fell 14.5% versus last year

to reach 34.8 million euros. But earnings at its plastics and

devices division, which makes syringes and injector pens, jumped

26.5% to 59.3 million euros.

($1 = 0.9234 euros)

(Reporting by Harshita Meenaktshi in Bengaluru; Editing by

Rashmi Aich and Mrigank Dhaniwala)